Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Pediatr Diabetes. 2019 Dec 16;21(2):349–357. doi: 10.1111/pedi.12948

TABLE 3.

Odds ratios from separate multinomial logistic regression models with past measurements related to diabetes control and complications* as covariate of interest and current screening criteria categories as 3-level outcome (“Meets Criteria” as reference for each measure).

Covariate of interest (model adjustments) Does not Meet Criteria vs. Meets Criteria DK/Not Sure vs. Meets Criteria

OR (95% CI)
p-value
OR (95% CI)
p-value

Past HbA1c (1-unit increase)
Model 0: no additional covariates [N=1973] 1.11 (1.05, 1.17) 1.24 (1.08, 1.43)
Model 1: adjusted for age, gender, & duration [N=1973] 1.06 (1.01, 1.13) 1.17 (1.01, 1.36)
Model 3: Model 1 + race/ethnicity [N=1972] 1.05 (0.99, 1.11) 1.10 (0.95, 1.28)
Model 4: Model 3 + insurance, income, parent education, DM care provider, & clinical site [N=1910] 1.04 (0.98, 1.10) 1.03 (0.87, 1.22)
Note - Models 2 and 5 (which add past HbA1c) not included because HbA1c is already in the model
Past HTN (Yes vs. No)
Model 0: no additional covariates [N=2032] 2.24 (1.13, 4.45) --- ---
Model 1: adjusted for age, gender, & duration [N=2032]^ 1.93 (0.96, 3.87) --- ---
Model 2: Model 1 + Past HbA1c [N=1872] ^ 1.33 (0.59, 3.00) --- ---
Model 3: Model 1 + race/ethnicity [N= 2031] 1.84 (0.91, 3.71) --- ---
Model 4: Model 3 + insurance, income, parent education, DM care provider, & clinical site [N=1972] 1.67 (0.81, 3.47) --- ---
Model 5: Model 4 + Past HbA1c [N= 1818] 1.13 (0.48, 2.63) --- ---

Past Albumin-to-Creatinine Ratio (ACR) (≥30 vs. <30)
Model 0: no additional covariates [N=1750] 1.03 (0.69, 1.55) 0.76 (0.48, 1.20)
Model 1: adjusted for age, gender, & duration [N=1750] 1.05 (0.70, 1.58) 0.75 (0.47, 1.20)
Model 2: Model 1 + Past HbA1c [N=1704] 0.98 (0.65, 1.49) 0.72 (0.45, 1.16)
Model 3: Model 1 + race/ethnicity [N= 1749] 1.05 (0.70, 1.58) 0.75 (0.47, 1.20)
Model 4: Model 3 + insurance, income, parent education, DM care provider, & clinical site [N=1692] 1.07 (0.70, 1.65) 0.70 (0.43, 1.15)
Model 5: Model 4 + Past HbA1c [N= 1648] 1.02 (0.65, 1.58) 0.67 (0.40, 1.11)

Past Dyslipidemia (Yes vs. No)
Model 0: no additional covariates [N=1793] 1.16 (0.81, 1.65) 0.82 (0.61, 1.11)
Model 1: adjusted for age, gender, & duration [N=1793] 0.89 (0.61, 1.29) 0.84 (0.62, 1.14)
Model 2: Model 1 + Past HbA1c [N=1787] 0.84 (0.58, 1.24) 0.73 (0.54, 1.00)
Model 3: Model 1 + race/ethnicity [N= 1792] 0.89 (0.61, 1.29) 0.84 (0.62, 1.13)
Model 4: Model 3 + insurance, income, parent education, DM care provider, & clinical site [N=1740] 0.88 (0.60, 1.30) 0.81 (0.59, 1.12)
Model 5: Model 4 + Past HbA1c [N= 1734] 0.87 (0.59, 1.29) 0.75 (0.54, 1.03)
*

Past measure not available for Peripheral Neuropathy or Retinopathy

Estimates not available due to empty cell in 3×2 table (HTN=Y, Screening=DK) – DK excluded, logistic model shown for “Does not Meet Criteria” vs. “Meets Criteria” (DK/Not Sure excluded)

^

Hosmer and Lemeshow Goodness-of-Fit test p<0.05